BREAKING
Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 18 minutes ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 22 minutes ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 1 hour ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 1 hour ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 1 hour ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 3 days ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 18 minutes ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 22 minutes ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 1 hour ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 1 hour ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 1 hour ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 3 days ago
ADVERTISEMENT
AlphaGraphs

Key highlights from Pfizer (PFE) Q2 2020 earnings results

Pfizer Inc. (NYSE:PFE) reported second quarter 2020 earnings results today. Revenues fell 11% to $11.8 billion. The decline was 9% on an operational basis. The top line number saw an impact of 4% from COVID-19, reflecting disruption to wellness visits for patients in the US as well as lower demand for certain products in China. […]

$PFE July 28, 2020 1 min read

Pfizer Inc. (NYSE:PFE) reported second quarter 2020 earnings results today.

Revenues fell 11% to $11.8 billion. The decline was 9% on an operational basis. The top line number saw an impact of 4% from COVID-19, reflecting disruption to wellness visits for patients in the US as well as lower demand for certain products in China.

On a reported basis, net income fell more than 30% to $3.4 billion, or $0.61 per share. On an adjusted basis, net income dropped 3% to $4.4 billion and EPS declined 2% to $0.78.

The company raised its guidance for fiscal year 2020 and now expects revenues to be $48.6-50.6 billion and adjusted EPS to be $2.85-2.95.

Past Performance

Click here to access the transcript for Pfizer Q2 2020 earnings conference call

ADVERTISEMENT
ADVERTISEMENT